Skip to main content

Welcome to Enveric Biosciences

Next Generation
Mental Health

Play Video

Company Overview

About Enveric Biosciences

Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. Leveraging its unique discovery and development platform, The Psybrary™, Enveric has created a robust Intellectual Property portfolio of New Chemical Entities for specific mental health indications.

Innovation in CNS

Enveric is advancing novel neuroplastogen therapeutics that have the potential to help millions of patients globally.

Development Pipeline



 Phase 1

 Phase 2

Phase 3


Difficult-to-Treat Mental Health Disorders
Prescription Model

Next Milestone: Pre-IND FDA Meeting



Psychiatric Disorders
Administered in Clinical Setting

Next Milestone: Inititate FIH in Australia